![Lionel Carnot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lionel Carnot
Direktor/Vorstandsmitglied bei
OCULIS HOLDING AG
Vermögen: 1 Mio $ am 30.06.2026
Profil
Lionel Carnot currently works at Bay City Capital LLC, as Managing Director & Advisor from 2005, iSTAR Medical SA, as Director from 2019, Priothera Ltd., as Director, Tallikut Pharmaceuticals, Inc., as Director, Oculis Holding AG, as Independent Director from 2017, Bek Venture, as Partner from 2012, and Oculis SA, as Board Member.
Mr. Carnot also formerly worked at iQone Healthcare Holding, as Director, Reliant Pharmaceuticals LLC, as Director from 2004 to 2008, NABsys, Inc., as Director from 2014 to 2015, Madrigal Pharmaceuticals, Inc., as Director, BioSeek, Inc., as Director, Pathway Diagnostics Ltd., as Director from 2004 to 2018, Nexus Dx, Inc., as Director, Interleukin Genetics, Inc., as Independent Director from 2013 to 2017, VIA Pharmaceuticals, Inc., as Director, Carballo Ltd., as Director from 2017 to 2019, Oracle Partners LP, as Principal from 1999 to 2000, Merus NV, as Member-Supervisory Board from 2010 to 2018, Accenture Plc, as Consultant, Booz Allen Hamilton, Inc., as Senior Associate from 1997 to 1998, Rhone-Poulenc Rorer Asia Pacific Ltd., as Head-Sales & Marketing from 1989 to 1991, Aventis, Inc., as Principal, Eli Lilly & Co., as Product Manager from 1995 to 1997, and The Pritzker Organization LLC, as Associate.
Mr. Carnot received his graduate degree from the University of Geneva and Masters Business Admin degree from INSEAD.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OCULIS HOLDING AG 0,16 % | 31.12.2025 | 90 753 ( 0,16 % ) | 1 Mio $ | 30.06.2026 |
Aktive Positionen von Lionel Carnot
| Unternehmen | Position | Beginn |
|---|---|---|
| OCULIS HOLDING AG | Direktor/Vorstandsmitglied | 01.12.2017 |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Berater | 01.01.2005 |
Priothera Ltd.
 Priothera Ltd. Pharmaceuticals: MajorHealth Technology Develops hematological malignancies cells | Direktor/Vorstandsmitglied | - |
iSTAR Medical SA
 iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions | Direktor/Vorstandsmitglied | 01.07.2019 |
Oculis SA
 Oculis SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that focuses on developing treatments for ophthalmic diseases | Direktor/Vorstandsmitglied | - |
Earlybird Venture Capital GmbH & Co. KG
 Earlybird Venture Capital GmbH & Co. KG Investment ManagersFinance Bek Ventures invests in companies located across the Europe. The firm targets companies operating in the fields of tech-enabled businesses in fintech/insurtech, enterprise software, and deep tech. It provides financing for early and growth stage capital requirements with an investment size of EUR 0.5 - 10 million. | Private Equity Investor | 01.01.2012 |
Tallikut Pharmaceuticals, Inc. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Lionel Carnot
| Unternehmen | Position | Ende |
|---|---|---|
Atlantic Therapeutics Ltd.
 Atlantic Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops medical devices, related software and connected health technologies | Direktor/Vorstandsmitglied | 01.01.2019 |
Pathway Diagnostics Ltd.
 Pathway Diagnostics Ltd. Medical DistributorsDistribution Services Provides clinical diagnostic products and medical instrumentation | Direktor/Vorstandsmitglied | 01.12.2018 |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Lionel Carnot
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
27
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 27 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops personalized health products | Health Technology |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
VIA Pharmaceuticals, Inc. /Old/
 VIA Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Accenture Plc
 Accenture Plc Information Technology ServicesTechnology Services Operates as an investment holding company with interest in providing management consulting, technology and outsourcing services | Technology Services |
Nexus Dx, Inc.
 Nexus Dx, Inc. Medical/Nursing ServicesHealth Services Provides diagnostics services | Health Services |
Oracle Partners LP | |
Booz Allen Hamilton, Inc.
 Booz Allen Hamilton, Inc. Packaged SoftwareTechnology Services Builds advanced technology to fast-track results for government—boosting efficiencies, saving money and safeguarding | Technology Services |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Earlybird Venture Capital GmbH & Co. KG
Earlybird Venture Capital GmbH & Co. KG Investment ManagersFinance Bek Ventures invests in companies located across the Europe. The firm targets companies operating in the fields of tech-enabled businesses in fintech/insurtech, enterprise software, and deep tech. It provides financing for early and growth stage capital requirements with an investment size of EUR 0.5 - 10 million. | Finance |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Finance |
BioSeek, Inc.
 BioSeek, Inc. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research services focusing on developing systems for the validation and development of novel human therapeutics | Commercial Services |
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NABsys, Inc.
 NABsys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops DNA analysis sequencing platform | Commercial Services |
The Pritzker Organization LLC
 The Pritzker Organization LLC Investment ManagersFinance The Pritzker Organization invests in companies located in the United States with an enterprise value of USD 100 - 1000 billion and an EBITDA of USD 10 - 150 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for growth stage capital requirements with an investment size of USD 75 -300 million for majority deals & USD 15 - 100 million for minority and structured deals. The firm also acquires majority and minority interest. | Finance |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Madrigal Pharmaceuticals, Inc. /Old/
 Madrigal Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases | Health Technology |
Tallikut Pharmaceuticals, Inc. | |
iSTAR Medical SA
iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions | Health Technology |
Rhone-Poulenc Rorer Asia Pacific Ltd. | |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that focuses on developing treatments for ophthalmic diseases | Commercial Services |
Atlantic Therapeutics Ltd.
Atlantic Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops medical devices, related software and connected health technologies | Health Technology |
iQone Healthcare Holding
 iQone Healthcare Holding Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Pathway Diagnostics Ltd.
Pathway Diagnostics Ltd. Medical DistributorsDistribution Services Provides clinical diagnostic products and medical instrumentation | Distribution Services |
Priothera Ltd.
Priothera Ltd. Pharmaceuticals: MajorHealth Technology Develops hematological malignancies cells | Health Technology |
Oculis Holding AG
 Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
